Details for 2022209104
Up to date per 01.04.2026
Actions
Details for 2022209104
Granted/Registered
European Patent
05.04.2023 A
14.02.2024 B1
20.12.2010
US
201061424967 P
A61K 9/28 20060101AFI20230227BHEP
Owner
Novartis AGLichtstrasse 35 4056 BaselCH
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
DEMARINI, Douglas, J. Collegeville, PA, 19426US
LE, Ngocdiep T. Collegeville, PA, 19426US
HENRIQUEZ, Francisco Collegeville, PA, 19426US
WANG, Lihong Collegeville, PA, 19426US
Information about Fees